Abstract 5: A 28-Day Prospective, Randomized, Double-Blind, Placebo Controlled Clinical Trial of Botulinum Toxin Type A for Raynaud's Phenomen.
Southern Illinois University, Springfield, IL.
Kelli N
KN
Webb
Nada N
NN
Berry
Reuben A
RA
Bueno
Michael W
MW
Neumeister